A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix (TGOG1005)

Clinical Trial ID NCT02482740

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02482740

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.	J Natl Cancer Inst	2010	3.95
2	Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.	Lancet	2007	3.35
3	Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.	Cancer Res	2003	2.32
4	Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.	Proc Natl Acad Sci U S A	1996	2.06
5	Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.	Cancer Res	2003	1.81
6	Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.	Cancer Res	2000	1.60
7	Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.	Int J Cancer	2006	1.57
8	Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.	Proc Natl Acad Sci U S A	2005	1.50
9	The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.	Cancer Res	2007	1.39
10	Time since first sexual intercourse and the risk of cervical cancer.	Int J Cancer	2011	1.12